Investigation path
FIND
Amgen
AMGN
RESOLVE
Ondo Assets · Backed Assets
2 issuers
TRACE
2 tokenized representations
AMGNon · wAMGNx
UnderScope Lens
Representation check
A compact comparison of Amgen across the reported market reference, tokenized aggregate, and issuer wrappers.
Market reference
—
No priced CMC venue reference
Tokenized aggregate
$425.02
Aggregate wrapper price
Wrapper dispersion
—
1 priced wrapper · single wrapper
The Lens needs both a priced tokenized representation and a priced CMC market reference to compare parity.
Underlier
Amgen[AMGN]
Stock · Biological Products, (No Diagnostic Substances) · Nasdaq
Tokenized price
$425.02
Rank #68
- Primary exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- Founded
- 1980-04-08
- Employees
- 28,000
- CIK
- 0000318154
Tokenized market cap
$6.99K
24h tokenized volume
$399.53K
Tokenized exposure
2wrappers
Source
Average across issuer wrappers, not a cash last
Real-world asset
About the underlier
The instrument being tokenized — not the on-chain wrapper.
Amgen is a leader in biotechnology-based human therapeutics. Flagship drugs include red blood cell boosters Epogen and Aranesp, immune system boosters Neupogen and Neulasta, and Enbrel and Otezla for inflammatory diseases. Amgen introduced its first cancer therapeutic, Vectibix, in 2006 and markets bone-strengthening drugs Prolia/Xgeva (approved 2010) and Evenity (2019). The acquisition of Onyx Pharmaceuticals…
- Rank
- 68
- Asset type
- Stock
- Primary exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- Founded
- 1980-04-08
- Employees
- 28,000